Vivactis HM3A is an consultancy company specialized in market access for pharmaceuticals, medical devices, vaccines and diagnostics. We are committed to deliver value and quality through objective and effective advice to clients on all matters related to obtaining and maintaining access to market in BeNeLux and other major EUR markets. Our services: • Strategic counselling we guide our clients to the best access route and pricing strategy. We built market access strategies enabling faster patient access to therapies. • Payers research we compile in depth knowledge and insight on how payers perceive value • Price determination we prepare and file national pricing dossiers. We set prices for optimal access and returns according to economic and international criteria. • Reimbursement filing we prepare and file national reimbursement dossiers. We aim for the best reimbursement possible for our client’s asset while keeping it affordable for payers. • Full health economics capabilities we build Cost-Effectiveness Models (CEM) and Budget Impact Models (BIM) and run Cost-Effectiveness Analysis (CEA) and Budget Impact Analysis (BIA). • Virtual advisory boards • Public Affairs we help to create a favorable environment in which companies can foster their treatments for patients globally • Regulatory services #marketaccess #pricing #reimbursement #medtech #pharma #consultancy